Carolyn Bertozzi accepted the Chemistry for the Future Solvay Prize and the nearly $335,000 award attached to it for the invention of bioorthogonal chemistry, which applies to physical organic and synthetic chemistry, biomedical science, and drug discovery. "We firmly believe that her work marks a spectacular, original advancement in chemistry, with likely life-saving applications in therapeutics," said Solvay CEO Ilham Kadri.